Abstract: The present invention relates to a pharmaceutical formulation comprising therapeutically effective amount of vildagliptin or pharmaceutically acceptable salt thereof and a diluent. Particularly, the ratio of vildagliptin to diluent is in the range of 0.04 to 0.24 (w/w).
Type:
Grant
Filed:
March 5, 2015
Date of Patent:
October 24, 2017
Assignee:
Sanovel IIac Sanayi Ve Ticaret Anonim Sirketi
Inventors:
Ali Turkyilmaz, Ali Hasan Turp, Mehtap Saydam, Onur Ulgen
Abstract: This invention relates to a pharmaceutical formulation, characterized by comprising flurbiprofen and polyvinylcaprolactam-polyvinyl acetate-polyethylene glycol graft copolymer.
Type:
Application
Filed:
December 20, 2012
Publication date:
October 30, 2014
Applicant:
Sanovel IIac Sanayi Ve Ticaret Anonim Sirketi
Inventors:
Umit Cifter, Ali Turkyilmaz, Nur Pahlivan Akalin, Ilayda Balci
Abstract: An orally-administrable controlled-release formulation, including pregabalin or a pharmaceutically acceptable salt of pregabalin and polycarbophil, as a controlled-release agent.
Type:
Application
Filed:
May 25, 2011
Publication date:
December 1, 2011
Applicant:
Sanovel IIac Sanayi Ve Ticaret Anonim Sirketi
Inventors:
Umit Cifter, Ali Turkyilmaz, Nur Pehlivan Akalin, Aylin Yildirim
Abstract: An oral pharmaceutical formulation of aliskiren, or a pharmaceutically acceptable salt or polymorph thereof, having at least two coating layers.
Type:
Application
Filed:
April 29, 2011
Publication date:
November 3, 2011
Applicant:
Sanovel IIac Sanayi Ve Ticaret Anonim Sirketi
Inventors:
Umit Cifter, Ali Turkyilmaz, Gulay Yelken
Abstract: A controlled-release pharmaceutical formulation, comprising pramipexole or a pharmaceutically acceptable salt of pramipexole, colloidal silicone dioxide, and glyceryl behenate.
Type:
Application
Filed:
March 10, 2011
Publication date:
September 15, 2011
Applicant:
Sanovel IIac Sanayi Ve Ticaret Anonim Sirketi
Inventors:
Umit Cifter, Ali Turkyilmaz, Hasan Ali Turp, Gulay Yelken, Levent Oner